Posterior leukoencephalopathy syndrome is a newly recognised brain disorder
that predominantly affects the cerebral white matter. Oedematous lesions p
articularly involve the posterior parietal and occipital lobes, and may spr
ead to basal ganglia, brain stem, and cerebellum. This rapidly evolving neu
rological condition is clinically characterised by headache, nausea and vom
iting, seizures, visual disturbances, altered sensorium, and occasionally f
ocal neurological deficit. Posterior leukoencephalopathy syndrome is often
associated with an abrupt increase in blood pressure and is usually seen in
patients with eclampsia, renal disease, and hypertensive encephalopathy. I
t is also seen in the patients treated with cytotoxic and immunosuppressive
drugs such as cyclosporin, tacrolimus, and interferon alfa. The lesions of
posterior leukoencephalopathy are best visualised with magnetic resonance
(MR) imaging. T2 weighted MR images, at the height of symptoms, characteris
tically show diffuse hyperintensity selectively involving the parieto-occip
ital white matter. Occasionally the lesions also involve the grey matter. C
omputed tomography can also be used satisfactorily to detect hypodense lesi
ons of posterior leukoencephalopathy. Early recognition of this condition i
s of paramount importance because prompt control of blood pressure or withd
rawal of immunosuppressive agents will cause reversal of the syndrome. Dela
y in the diagnosis and treatment can result in permanent damage to affected
brain tissues.